Latest news
Analyst Reiterates Buy on Opus Genetics as Pivotal OPGx‑LCA5 Trial Advances and Cash Runway Extends Into 2028 - tipranks.comtipranks.com · Fri, 07 Aug 2026 09:02:30 GMTRitu Baral Reiterates Buy on COMPASS Pathways as COMP360 Advances Toward 2027 Launch with Strong Cash Runway - tipranks.comtipranks.com · Thu, 06 Aug 2026 11:29:52 GMT